GENELABS TECHNOLOGIES
As of January 6, 2009, Genelabs Technologies Inc. was acquired by SmithKline Beecham Corporation. Genelabs Technologies, Inc., a biopharmaceutical company, engages in the discovery and development of infectious disease therapies to improve human health. The company's product pipeline consists of infectious disease projects focusing on Hepatitis C virus infection; and late-stage clinical assets, including an investigational vaccine for hepatitis E virus that is being developed by GlaxoSmithKline;... and Prestara, an investigational drug for systemic lupus erythematosus. It has license and collaboration agreement with the Novartis Institutes for BioMedical Research for HCV polymerase non-nucleoside discovery research. Genelabs Technologies also has a collaborative research agreement with the National Health Research Institutes and Genovate Biotechnology Co., Ltd. to discover and develop compounds that target the hepatitis C virus. The company was founded in 1983 and is headquartered in Redwood City, California.
GENELABS TECHNOLOGIES
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
1983-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.genelabs.com
Total Employee:
51+
Status:
Active
Contact:
650-369-9500
Total Funding:
17.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress IPv6 Cloudflare Cloudflare Hosting Cloudflare Network Error Logging Cloudflare DNS Cloudflare SSL
Current Employees Featured
Founder
Investors List
Paramount BioCapital Asset Management
Paramount BioCapital Asset Management investment in Venture Round - Genelabs Technologies
Merlin Biomed
Merlin Biomed investment in Venture Round - Genelabs Technologies
Fort Mason Capital
Fort Mason Capital investment in Venture Round - Genelabs Technologies
RA Capital Management
RA Capital Management investment in Venture Round - Genelabs Technologies
Centrecourt Asset Management
Centrecourt Asset Management investment in Venture Round - Genelabs Technologies
Official Site Inspections
http://www.genelabs.com
- Host name: 172.67.130.47
- IP address: 172.67.130.47
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Genelabs Technologies"
Genelabs Technologies - Crunchbase Company Profile & Funding
As of January 6, 2009, Genelabs Technologies Inc. was acquired by SmithKline Beecham Corporation. Genelabs Technologies, Inc., a biopharmaceutical company, engages in the …See details»
GlaxoSmithKline to Acquire Genelabs Technologies to Increase …
Oct 30, 2008 Genelabs will become part of GSK's Drug Discovery organization and its HCV programs will be consolidated into the broad therapeutic approaches already underway …See details»
Information | Drug Discovery - genelabs.com
It is on the World Health Organization’s List of Essential Medicines, a list of the most important medication needed in a basic health system. The chief characteristic of proteins The region of …See details»
Genelabs Technologies, Inc. - Drug pipelines, Patents ... - Patsnap
Explore Genelabs Technologies, Inc. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 3 news, and 36 literature, Drug:Trichosanthin, GL-2021, GL-59728, GL-48656, …See details»
Genelabs Technologies, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Genelabs Technologies, Inc. of Redwood City, CA. Get the latest business insights from Dun & Bradstreet.See details»
Genelabs Technologies - LinkedIn
Genelabs Technologies | 501 followers on LinkedIn. Genelabs is a biopharmaceutical company focused on the discovery and development of novel compounds for infectious diseases. In …See details»
GlaxoSmithKline To Acquire Genelabs Technologies To Increase …
Nov 3, 2008 GlaxoSmithKline and Genelabs Technologies, Inc. announced recently that they have entered into a definitive agreement pursuant to which GSK will acquire Genelabs for …See details»
GlaxoSmithKline to Acquire Genelabs to Increase Focus on Small …
Oct 30, 2008 GlaxoSmithKline and Genelabs Technologies, Inc. have announced that they have entered into a definitive agreement pursuant to which GSK will acquire Genelabs for …See details»
Genelabs Technologies Inc - Company Profile and News
Genelabs Technologies, Inc. doing business as Genelabs Delaware, is a biopharmaceutical company. The Company is concentratingits capabilities on an investigational drug for women …See details»
Genelabs - Crunchbase Company Profile & Funding
Genelabs is a microbiological laboratory that provides biopathology and molecular diagnosis services using advanced diagnostic tools. ... Products. Resources. Pricing. Resources. Log In. …See details»
Drug Discovery | News and information in drug research
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through …See details»
Genelabs Technologies, Inc. - VentureRadar
Genelabs Technologies, Inc. VentureRadar profile. Find out more about Genelabs Technologies, Inc. including the VentureRadar Innovation and Growth scores, Similar Companies and more. …See details»
GeneLab - NASA
Nov 1, 2024 All datasets hosted on GeneLab are carefully curated to include all essential metadata associated with each experiment. The meticulous curation and organization of data …See details»
Genelabs Technologies - PitchBook
Genelabs Technologies General Information Description. Developer of pharmaceutical products based in Redwood City, California. The company discovers and develops pharmaceutical …See details»
GSK buys Genelabs for $57M - Fierce Biotech
Oct 30, 2008 In a move designed to bolster it's hepatitis C offerings, GlaxoSmithKline is buying Redwood City, CA-based Genelabs Technologies for $57 million. GSK will pay $1.30 per …See details»
Researcher’s Guide to: GeneLab - NASA
June 2017 Edition. By Olga Stotzky Peter B. Tran Sigrid Reinsch, PhD Sylvain Costes, PhD Dan Berrios, MD, MPH, PhD Sandy Dueck . NASA initiated GeneLab—a multiyear, multiphase …See details»
What is NASA’s GeneLab?
Aug 15, 2022 An Open-Data Treasure Trove. GeneLab’s data is available through an interactive, open-access data system, where users can upload, download, store, search, share, transfer, …See details»
GeneLab - Wikipedia
GeneLab is an open-access, [1] collaborative analysis platform for space bioscience research. [2] [3] GeneLab aims to maximize the research resulting from experiments aboard the …See details»
The Technology - Genelabs
Genelabs utilizes the NGS workflow of the Genestudio S5 NGS system launched by ThermoFisher Scientific (USA), offers speed, accuracy, and flexibility for different gene panels, …See details»
GeneLab: Omics database for spaceflight experiments
Oct 17, 2018 Metadata organization using ISAcreator. (A) GeneLab uses the ISAcreator tool to create, edit and visualize ISA-Tab files allowing submitter to provide detailed information …See details»